tradingkey.logo
tradingkey.logo
検索

Rockwell Medical Inc

RMTI
ウォッチリストに追加
8.630USD
+0.260+3.11%
終値 09-28 16:00(ET)
34.09M時価総額
損失額直近12ヶ月PER

Rockwell Medical Incについて 企業名

Rockwell Medical, Inc. is a healthcare company. The Company develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers worldwide. The Company operates in the hemodialysis market, which involves the manufacture, sale and distribution of hemodialysis products to hemodialysis clinics, including pharmaceuticals, dialysis concentrates, dialysis kits and other ancillary products used in the dialysis process. Its hemodialysis concentrates products are used to sustain a patient's life by removing toxins and balancing electrolytes in a dialysis patient’s bloodstream. The Company is the supplier of liquid and dry, acid and bicarbonate concentrates for dialysis patients in the United States. The Company manufactures hemodialysis concentrates at its facilities in Michigan, South Carolina, and Texas, and the Company manufactures its dry acid concentrate mixers at its facility in Iowa.

Rockwell Medical Inc プロフィール

企業コードRMTI
会社名Rockwell Medical Inc
上場日Jan 27, 1998
最高経営責任者「CEO」Strobeck (Mark)
従業員数244
証券種類Ordinary Share
決算期末Jan 27
本社所在地30142 Wixom Road
都市WIXOM
証券取引所NASDAQ OMX - NASDAQ BASIC
国United States of America
郵便番号48393
電話番号18004493353
ウェブサイトhttps://www.rockwellmed.com/
企業コードRMTI
上場日Jan 27, 1998
最高経営責任者「CEO」Strobeck (Mark)

Rockwell Medical Incの経営陣

会社名
会社名/ポジション
ポジション
株式保有
変動額
Dr. Mark Strobeck, Ph.D.
Dr. Mark Strobeck, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
40.40K
+74.27%
Mr. Timothy Chole
Mr. Timothy Chole
Senior Vice President, Chief Commercial Officer
Senior Vice President, Chief Commercial Officer
27.57K
+54.41%
Mr. John G. Cooper, CPA
Mr. John G. Cooper, CPA
Independent Director
Independent Director
24.18K
+39.84%
Ms. Megan Timmins, J.D.
Ms. Megan Timmins, J.D.
Executive Vice President, Chief Legal Officer, Secretary
Executive Vice President, Chief Legal Officer, Secretary
21.18K
+70.80%
Dr. Joan Lau, Ph.D.
Dr. Joan Lau, Ph.D.
Independent Director
Independent Director
20.94K
+45.99%
Mr. Jesse Neri
Mr. Jesse Neri
Chief Financial Officer, Senior Vice President - Finance
Chief Financial Officer, Senior Vice President - Finance
16.87K
+88.93%
Mr. Mark H. Ravich
Mr. Mark H. Ravich
Independent Director
Independent Director
15.11K
--
Mr. Robert S. Radie
Mr. Robert S. Radie
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Dr. Allen R. Nissenson, M.D.
Dr. Allen R. Nissenson, M.D.
Independent Director
Independent Director
--
--
Ms. Heather R. Hunter
Ms. Heather R. Hunter
Chief Operating Officer, Senior Vice President
Chief Operating Officer, Senior Vice President
--
--
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Dr. Mark Strobeck, Ph.D.
Dr. Mark Strobeck, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
40.40K
+74.27%
Mr. Timothy Chole
Mr. Timothy Chole
Senior Vice President, Chief Commercial Officer
Senior Vice President, Chief Commercial Officer
27.57K
+54.41%
Mr. John G. Cooper, CPA
Mr. John G. Cooper, CPA
Independent Director
Independent Director
24.18K
+39.84%
Ms. Megan Timmins, J.D.
Ms. Megan Timmins, J.D.
Executive Vice President, Chief Legal Officer, Secretary
Executive Vice President, Chief Legal Officer, Secretary
21.18K
+70.80%
Dr. Joan Lau, Ph.D.
Dr. Joan Lau, Ph.D.
Independent Director
Independent Director
20.94K
+45.99%
Mr. Jesse Neri
Mr. Jesse Neri
Chief Financial Officer, Senior Vice President - Finance
Chief Financial Officer, Senior Vice President - Finance
16.87K
+88.93%

よくある質問

Rockwell Medical Incの上位5名の株主は誰ですか?

Rockwell Medical Incの上位5名の株主は以下のとおりです。Dr. Mark Strobeck, Ph.D.

Rockwell Medical Inc(RMTI)の株式を保有している機関の数はいくつですか?

2026Q1時点で、Rockwell Medical Incの株式を保有している機関は98社あり、保有株式の総市場価値は約5.15Mで、全体の13.04%を占めています。2025Q4と比較して、機関の持ち株は-2200637.00増加しています。
tradingkey.logo
リスク告知:当社ウェブサイト及びモバイルアプリは特定の投資商品に関する一般的な情報のみを提供しており、Finsightsは金融アドバイスや投資商品の推奨を行うものではありません。本情報の提供をもってFinsightsが投資助言を行っていると解釈されることはありません。
投資商品には元本割れを含む重大なリスクが伴い、全ての投資家に適するものではありません。なお、過去の運用実績は将来の成果を保証するものではありません。
Finsightsは、第三者広告主または提携先が当社ウェブサイト・モバイルアプリ上に広告を掲載することを許可する場合があり、これら広告主から広告への反応に基づく報酬を受けることがあります。
© 著作権: FINSIGHTS MEDIA PTE. LTD. 無断複写・転載を禁じます。